Multi-target MET tyrosine kinase inhibitors (TKIs) are a class of drugs ,designed to inhibit the MET receptor tyrosine kinase and other related or unrelated tyrosine kinases to block multiple signaling pathways involved in cancer progression.
The global Multi-target MET TKIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Multi-target MET TKIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Multi-target MET TKIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Multi-target MET TKIs include Pfizer, Exelixis, MSN Labs, Stada Arzneimittel, Teva, Cipla, BDR Pharma, Elemento Pharma, Beacon Pharmaceuticals, Wanbang Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Multi-target MET TKIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-target MET TKIs.
The Multi-target MET TKIs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Multi-target MET TKIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi-target MET TKIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Exelixis
MSN Labs
Stada Arzneimittel
Teva
Cipla
BDR Pharma
Elemento Pharma
Beacon Pharmaceuticals
Wanbang Biopharmaceuticals
Drug International
Genvio Pharma
Everest Pharmaceuticals
Zydus
Segment by Type
cabozantinib
Crizotinib
Other
Segment by Application
Non-small Cell Lung Cancer
Medullary Thyroid Cancer
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Multi-target MET TKIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Multi-target MET TKIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Multi-target MET TKIs Market Overview
1.1 Product Definition
1.2 Multi-target MET TKIs by Type
1.2.1 Global Multi-target MET TKIs Market Value Comparison by Type (2024-2030)
1.2.2 cabozantinib
1.2.3 Crizotinib
1.2.4 Other
1.3 Multi-target MET TKIs by Application
1.3.1 Global Multi-target MET TKIs Market Value by Application (2024-2030)
1.3.2 Non-small Cell Lung Cancer
1.3.3 Medullary Thyroid Cancer
1.3.4 Other
1.4 Global Multi-target MET TKIs Market Size Estimates and Forecasts
1.4.1 Global Multi-target MET TKIs Revenue 2019-2030
1.4.2 Global Multi-target MET TKIs Sales 2019-2030
1.4.3 Global Multi-target MET TKIs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Multi-target MET TKIs Market Competition by Manufacturers
2.1 Global Multi-target MET TKIs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Multi-target MET TKIs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Multi-target MET TKIs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Multi-target MET TKIs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Multi-target MET TKIs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Multi-target MET TKIs, Product Type & Application
2.7 Global Key Manufacturers of Multi-target MET TKIs, Date of Enter into This Industry
2.8 Global Multi-target MET TKIs Market Competitive Situation and Trends
2.8.1 Global Multi-target MET TKIs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Multi-target MET TKIs Players Market Share by Revenue
2.8.3 Global Multi-target MET TKIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Multi-target MET TKIs Market Scenario by Region
3.1 Global Multi-target MET TKIs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Multi-target MET TKIs Sales by Region: 2019-2030
3.2.1 Global Multi-target MET TKIs Sales by Region: 2019-2024
3.2.2 Global Multi-target MET TKIs Sales by Region: 2025-2030
3.3 Global Multi-target MET TKIs Revenue by Region: 2019-2030
3.3.1 Global Multi-target MET TKIs Revenue by Region: 2019-2024
3.3.2 Global Multi-target MET TKIs Revenue by Region: 2025-2030
3.4 North America Multi-target MET TKIs Market Facts & Figures by Country
3.4.1 North America Multi-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Multi-target MET TKIs Sales by Country (2019-2030)
3.4.3 North America Multi-target MET TKIs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Multi-target MET TKIs Market Facts & Figures by Country
3.5.1 Europe Multi-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Multi-target MET TKIs Sales by Country (2019-2030)
3.5.3 Europe Multi-target MET TKIs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Multi-target MET TKIs Market Facts & Figures by Region
3.6.1 Asia Pacific Multi-target MET TKIs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Multi-target MET TKIs Sales by Region (2019-2030)
3.6.3 Asia Pacific Multi-target MET TKIs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Multi-target MET TKIs Market Facts & Figures by Country
3.7.1 Latin America Multi-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Multi-target MET TKIs Sales by Country (2019-2030)
3.7.3 Latin America Multi-target MET TKIs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Multi-target MET TKIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Multi-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Multi-target MET TKIs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Multi-target MET TKIs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Multi-target MET TKIs Sales by Type (2019-2030)
4.1.1 Global Multi-target MET TKIs Sales by Type (2019-2024)
4.1.2 Global Multi-target MET TKIs Sales by Type (2025-2030)
4.1.3 Global Multi-target MET TKIs Sales Market Share by Type (2019-2030)
4.2 Global Multi-target MET TKIs Revenue by Type (2019-2030)
4.2.1 Global Multi-target MET TKIs Revenue by Type (2019-2024)
4.2.2 Global Multi-target MET TKIs Revenue by Type (2025-2030)
4.2.3 Global Multi-target MET TKIs Revenue Market Share by Type (2019-2030)
4.3 Global Multi-target MET TKIs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Multi-target MET TKIs Sales by Application (2019-2030)
5.1.1 Global Multi-target MET TKIs Sales by Application (2019-2024)
5.1.2 Global Multi-target MET TKIs Sales by Application (2025-2030)
5.1.3 Global Multi-target MET TKIs Sales Market Share by Application (2019-2030)
5.2 Global Multi-target MET TKIs Revenue by Application (2019-2030)
5.2.1 Global Multi-target MET TKIs Revenue by Application (2019-2024)
5.2.2 Global Multi-target MET TKIs Revenue by Application (2025-2030)
5.2.3 Global Multi-target MET TKIs Revenue Market Share by Application (2019-2030)
5.3 Global Multi-target MET TKIs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Multi-target MET TKIs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Exelixis
6.2.1 Exelixis Company Information
6.2.2 Exelixis Description and Business Overview
6.2.3 Exelixis Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Exelixis Multi-target MET TKIs Product Portfolio
6.2.5 Exelixis Recent Developments/Updates
6.3 MSN Labs
6.3.1 MSN Labs Company Information
6.3.2 MSN Labs Description and Business Overview
6.3.3 MSN Labs Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSN Labs Multi-target MET TKIs Product Portfolio
6.3.5 MSN Labs Recent Developments/Updates
6.4 Stada Arzneimittel
6.4.1 Stada Arzneimittel Company Information
6.4.2 Stada Arzneimittel Description and Business Overview
6.4.3 Stada Arzneimittel Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Stada Arzneimittel Multi-target MET TKIs Product Portfolio
6.4.5 Stada Arzneimittel Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Multi-target MET TKIs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Multi-target MET TKIs Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 BDR Pharma
6.7.1 BDR Pharma Company Information
6.7.2 BDR Pharma Description and Business Overview
6.7.3 BDR Pharma Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 BDR Pharma Multi-target MET TKIs Product Portfolio
6.7.5 BDR Pharma Recent Developments/Updates
6.8 Elemento Pharma
6.8.1 Elemento Pharma Company Information
6.8.2 Elemento Pharma Description and Business Overview
6.8.3 Elemento Pharma Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Elemento Pharma Multi-target MET TKIs Product Portfolio
6.8.5 Elemento Pharma Recent Developments/Updates
6.9 Beacon Pharmaceuticals
6.9.1 Beacon Pharmaceuticals Company Information
6.9.2 Beacon Pharmaceuticals Description and Business Overview
6.9.3 Beacon Pharmaceuticals Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beacon Pharmaceuticals Multi-target MET TKIs Product Portfolio
6.9.5 Beacon Pharmaceuticals Recent Developments/Updates
6.10 Wanbang Biopharmaceuticals
6.10.1 Wanbang Biopharmaceuticals Company Information
6.10.2 Wanbang Biopharmaceuticals Description and Business Overview
6.10.3 Wanbang Biopharmaceuticals Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Wanbang Biopharmaceuticals Multi-target MET TKIs Product Portfolio
6.10.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.11 Drug International
6.11.1 Drug International Company Information
6.11.2 Drug International Description and Business Overview
6.11.3 Drug International Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Drug International Multi-target MET TKIs Product Portfolio
6.11.5 Drug International Recent Developments/Updates
6.12 Genvio Pharma
6.12.1 Genvio Pharma Company Information
6.12.2 Genvio Pharma Description and Business Overview
6.12.3 Genvio Pharma Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Genvio Pharma Multi-target MET TKIs Product Portfolio
6.12.5 Genvio Pharma Recent Developments/Updates
6.13 Everest Pharmaceuticals
6.13.1 Everest Pharmaceuticals Company Information
6.13.2 Everest Pharmaceuticals Description and Business Overview
6.13.3 Everest Pharmaceuticals Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Everest Pharmaceuticals Multi-target MET TKIs Product Portfolio
6.13.5 Everest Pharmaceuticals Recent Developments/Updates
6.14 Zydus
6.14.1 Zydus Company Information
6.14.2 Zydus Description and Business Overview
6.14.3 Zydus Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zydus Multi-target MET TKIs Product Portfolio
6.14.5 Zydus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Multi-target MET TKIs Industry Chain Analysis
7.2 Multi-target MET TKIs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Multi-target MET TKIs Production Mode & Process
7.4 Multi-target MET TKIs Sales and Marketing
7.4.1 Multi-target MET TKIs Sales Channels
7.4.2 Multi-target MET TKIs Distributors
7.5 Multi-target MET TKIs Customers
8 Multi-target MET TKIs Market Dynamics
8.1 Multi-target MET TKIs Industry Trends
8.2 Multi-target MET TKIs Market Drivers
8.3 Multi-target MET TKIs Market Challenges
8.4 Multi-target MET TKIs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Pfizer
Exelixis
MSN Labs
Stada Arzneimittel
Teva
Cipla
BDR Pharma
Elemento Pharma
Beacon Pharmaceuticals
Wanbang Biopharmaceuticals
Drug International
Genvio Pharma
Everest Pharmaceuticals
Zydus
听
听
*If Applicable.